Is Ascendis Pharma A/S (ASND) a Buy, Sell, or Hold?
NASDAQ : ASND
Ascendis Pharma A/S — Analyst Ratings
$243.45 USD
-$0.46 (-0.19%)
- Volume
- 519.5K
- Average Volume
- 686.46K
- Market Capitalization
- $15.12B
- P/E Ratio
- 25.82
- Dividend Yield
- 0.00%
- Price Target
- $277.50
- Year High
- $282.15
- Year Low
- $173.33
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.00
Analyst Consensus Summary
Consensus Rating
Neutral
25 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-12.3%
vs Current Price
Price Target
$277.50
Average TargetPrice Target Range
Lowest Target
$255.00
-4.5% DOWNSIDE
Average Target
$277.50
Median Estimate
Highest Target
$345.00
-29.4% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 25
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 23 | 2 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Alex Thompson | $332 | $241.38 | 2026-03-04 03:22 PM | 37.5% |
| Wolfe Research | Kalpit Patel | $260 | $231.4606 | 2026-03-02 10:59 AM | 12.3% |
| Cantor Fitzgerald | Li Watsek | $300 | $231.4284 | 2026-03-02 10:38 AM | 29.6% |
| Evercore ISI | Josh Schimmer | $324 | $234.07 | 2026-03-02 10:03 AM | 38.4% |